Company: CSDX
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001214659-25-016410
Chunk: 22

Company: CS DIAGNOSTICS CORP.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 22
---

this Report, the Company also continued to evaluate strategic financing and partnership opportunities to support commercialization and
regulatory initiatives. No definitive agreements have been executed as of the filing date.

There have been no material changes to the composition of the Board
of Directors or executive officers since the Company’s last periodic filing.

Item 6. Exhibits.

  Exhibit      Description                                                                                                                                            Filed Herewith /           
      No.                                                                                                                                                             Incorporated by Reference  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     31.1      Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934                        Filed herewith             
     31.2      Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934                        Filed herewith             
     32.1      Certification of Principal Executive Officer pursuant to 18 U. S. C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002      Furnished herewith         
     32.2      Certification of Principal Financial Officer pursuant to 18 U. S. C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002      Furnished herewith         
      104      Cover Page Interactive Data File (the Inline XBRL document contained in this Form 10-Q is embedded within the Inline XBRL document)                    Filed herewith             

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

  Date: November 13, 2025      By:      /s/ Mohammad EsSayed         
 ─────────────────────────────────────────────────────────────────────
                                        Mohammad EsSayed             
                                        Principal Financial Officer